Finance

Lists
600867:SHA
Tonghua Dongbao Pharmaceutical Co Ltd
CNÂ¥8.01
+0.50%
(+0.040) 1D
Nov 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600867...
Open
CNÂ¥7.98
High
CNÂ¥8.07
Low
CNÂ¥7.93
Mkt. cap
15.61B
Avg. vol.
14.58M
Volume
24.33M
Dividend
3.75%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 5, 2026
P/E ratio
28.93
52-wk high
CNÂ¥10.67
52-wk low
CNÂ¥7.16
EPS
CNÂ¥0.28
Shares outstanding
2.03B
No. of employees
3K
Open
CNÂ¥7.98
High
CNÂ¥8.07
Low
CNÂ¥7.93
Mkt. cap
15.61B
Avg. vol.
14.58M
Volume
24.33M
Dividend
3.75%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 5, 2026
P/E ratio
28.93
52-wk high
CNÂ¥10.67
52-wk low
CNÂ¥7.16
EPS
CNÂ¥0.28
Shares outstanding
2.03B
No. of employees
3K
News stories
From web sources and news partners
About Tonghua Dongbao Pharmaceutical Co Ltd
CEO-
Employees3.35K
Founded1985
Headquarters-
SectorPharmaceutical industry
Industry-
Websitethdb.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
767.64M
747.65M
805.18M
915.98M
Cost of goods sold
273.45M
212.16M
259.79M
248.00M
Cost of revenue
273.45M
212.16M
259.79M
248.00M
Research and development expenses
50.69M
35.81M
39.78M
43.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
275.71M
337.36M
344.32M
300.82M
Operating expense
336.75M
377.09M
386.31M
348.25M
Total operating expenses
610.21M
589.25M
646.10M
596.25M
Operating income
157.43M
158.40M
159.08M
319.73M
Other non operating income
-701.80K
-138.08K
-1.67M
-3.62M
EBT including unusual items
36.69M
166.32M
182.67M
266.53M
EBT excluding unusual items
159.07M
167.61M
179.96M
305.76M
Income tax expense
27.37M
44.93M
34.39M
48.73M
Effective tax rate
74.60%
27.01%
18.83%
18.28%
Other operating expenses
10.44M
2.16M
2.96M
4.82M
Net income
16.82M
126.80M
168.90M
229.71M
Net profit margin
2.19%
16.96%
20.98%
25.08%
Earnings per share
-
-
-
-
Interest and investment income
8.08M
13.26M
26.94M
-
Interest expense
-5.12M
-3.91M
-5.11M
-9.62M
Net interest expenses
2.96M
9.35M
21.83M
-9.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
223.00M
223.97M
231.48M
385.29M
Gain or loss from assets sale
3.12M
-
516.05K
-516.05K
Upcoming events
AI content may include mistakes. Learn more
Google apps